ইঙ্গিত ও ব্যবহার
Santinal MR capsule is used for the secondary prevention of ischaemic stroke and transient ischaemic attacks, either on its own or together with aspirin. It is also used alongside oral anti-coagulant therapy to help prevent thromboembolism in patients with prosthetic heart valves.
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Adults, including the elderly: The recommended dose is one 200 mg capsule twice daily, usually one in the morning and one in the evening, preferably with meals. The capsules should be swallowed whole, without chewing. Children: Dipyridamole 200 mg capsule is not recommended for children.
পার্শ্বপ্রতিক্রিয়া
The following side effects have been reported, Blood and lymphatic system disorders- Thrombocytopenia; Immune system disorders- Hypersensitivity, Angioedema; Nervous system disorders- Headache, Dizziness; Cardiac disorders- Angina pectoris, Tachycardia; Vascular disorders- Hypotension, Hot flush; Respiratory, thoracic and mediastinal disorders- Bronchospasm; Gastrointestinal disorders- Diarrhoea, Nausea, Vomiting; Skin and subcutaneous tissue disorders- Rash, Urticaria; Musculoskeletal, connective tissue and bone disorders- Myalgia, Injury, poisoning and procedural complications- post procedural haemorrhage, operative haemorrhage.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
In patients with rapidly worsening angina, subvalvular aortic stenosis, haemodynamic instability associated with recent MI or coagulation disorders esp when given IV during myocardial imaging. Hypotension, unstable angina, aortic stenosis. Pregnancy and lactation. Safety and efficacy are not established in childn < 12 yrs.
নিষেধাজ্ঞা
Hypersensitivity to any component of the product. Warnings and precautions: among other properties, dipyridamole acts as a potent vasodilator. It should therefore be used with caution in patients with severe coronary artery disease, including unstable angina and/or a recent heart attack, obstruction of the left ventricular outflow tract, or haemodynamic instability such as decompensated heart failure. Patients being treated with regular oral doses of Dipyridamole MR should not also be given intravenous dipyridamole. Clinical experience suggests that patients on oral dipyridamole who also need pharmacological stress testing with intravenous dipyridamole should stop oral dipyridamole containing medicines for twenty four hours before the test. In patients with myasthenia gravis, therapy may need to be readjusted after changes in dipyridamole dosage. Dipyridamole should be used with caution in patients with coagulation disorders.